Dev V, Eigler N, Fishbein M C, Tian Y, Hickey A, Rechavia E, Forrester J S, Litvack F
Department of Medicine, Cardiovascular Intervention Center, Los Angeles, California, USA.
Cathet Cardiovasc Diagn. 1997 Jul;41(3):324-32. doi: 10.1002/(sici)1097-0304(199707)41:3<324::aid-ccd14>3.0.co;2-n.
This study was designed to evaluate the feasibility of applying locally delivered polylactic acid microspheres for drug delivery to the arterial wall. To study drug persistence, rhodamine-loaded microspheres were infused into one carotid artery of 14 rabbits and plain rhodamine solution into the other by using a porous balloon. To study tissue response, plain microspheres and dexamethasone-loaded microspheres were infused into the carotid arteries of another group of rabbits. To study the antiproliferative effects of locally delivered drug, 20 rabbits were subjected to overstretch balloon injury to both carotid arteries and divided into 4 groups: injury alone, plain microspheres, dexamethasone-loaded microspheres, and microspheres containing colchicine and dexamethasone. Fluorescent microspheres persisted in the vessel wall for 4 wk, whereas rhodamine without microspheres disappeared at 72 h. Histopathologic studies in arteries infused with unloaded microspheres showed inflammatory cell infiltrate with polymorphonuclear cells at 1 wk and macrophages and giant cells at 4 wk. Arteries infused with dexamethasone-loaded microspheres did not show any inflammatory cell infiltrate. Local delivery of dexamethasone or dexamethasone plus colchicine did not result in significant change in the intima-to-media ratio or in residual lumen following balloon injury. Polylactic acid microspheres may be used for prolonged delivery of drugs or other bioactive agents locally to the arterial wall. They induce an inflammatory reaction that is suppressable by dexamethasone in the microspheres. Dexamethasone or dexamethasone and colchicine delivered via this system, however, failed to reduce the degree of intimal hyperplasia after overstretch balloon injury to the rabbit carotid arteries.
本研究旨在评估局部递送聚乳酸微球用于向动脉壁给药的可行性。为研究药物持久性,将负载罗丹明的微球通过多孔球囊注入14只兔子的一侧颈动脉,将普通罗丹明溶液注入另一侧颈动脉。为研究组织反应,将普通微球和负载地塞米松的微球注入另一组兔子的颈动脉。为研究局部递送药物的抗增殖作用,对20只兔子的双侧颈动脉进行过度扩张球囊损伤,并分为4组:单纯损伤组、普通微球组、负载地塞米松的微球组和含有秋水仙碱和地塞米松的微球组。荧光微球在血管壁中持续存在4周,而未包裹微球的罗丹明在72小时后消失。对注入未负载微球的动脉进行组织病理学研究显示,在1周时出现多形核细胞炎症细胞浸润,在4周时出现巨噬细胞和巨细胞。注入负载地塞米松微球的动脉未显示任何炎症细胞浸润。局部递送地塞米松或地塞米松加秋水仙碱在球囊损伤后内膜与中膜比值或残余管腔方面未导致显著变化。聚乳酸微球可用于将药物或其他生物活性剂局部长期递送至动脉壁。它们会引发炎症反应,而微球中的地塞米松可抑制这种反应。然而,通过该系统递送的地塞米松或地塞米松与秋水仙碱未能减轻兔子颈动脉过度扩张球囊损伤后的内膜增生程度。